Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

Choueiri, T. K., Labaki, C., Bakouny, Z., Hsu, C.-Y., Schmidt, A. L., de Lima Lopes, G., Hwang, C., Singh, S. R. K., Jani, C., Weissmann, L. B., Griffiths, E. A., Halabi, S., Wu, U., Berg, S., O’Connor, T. E., Wise-Draper, T. M., Panagiotou, O. A., Klein, E. J., Joshi, M., … Warner, J. L. (2023). Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium. The Lancet Regional Health - Americas, 19, 100445. https://doi.org/10.1016/j.lana.2023.100445
Authors:
Toni K Choueiri
Chris Labaki
Ziad Bakouny
Chih-Yuan Hsu
Andrew L Schmidt
Gilberto de Lima Lopes
Clara Hwang
Sunny R K Singh
Chinmay Jani
Lisa B Weissmann
Elizabeth A Griffiths
Susan Halabi
Ulysses Wu
Stephanie Berg
Timothy E O'Connor
Trisha M Wise-Draper
Orestis A Panagiotou
Elizabeth J Klein
Monika Joshi
Fares Yared
Miriam Santos Dutra
Na Tosha N Gatson
Sibel Blau
Harpreet Singh
Rahul Nanchal
Rana R McKay
Taylor K Nonato
Ryann Quinn
Samuel M Rubinstein
Matthew Puc
Blanche H Mavromatis
Praveen Vikas
Bryan Faller
Howard A Zaren
Salvatore Del Prete
Karen Russell
Daniel Y Reuben
Melissa K Accordino
Harpreet Singh
Christopher R Friese
Sanjay Mishra
Donna R Rivera
Yu Shyr
Dimitrios Farmakiotis
Jeremy L Warner
Affiliated Authors:
Melissa K Accordino
Columbia Affiliation:
Author Keywords:
breakthrough infection
cancer
covid-19
mrna vaccine
sars-cov-2
vaccination
elink
Publication Type:
Article
Unique ID:
10.1016/j.lana.2023.100445
PMID:
36818595
DOI:
10.1016/j.lana.2023.100445
Journal:
Lancet Regional Health: Americas
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: